Kickoff questions determine validation quality
A validation kickoff should create clarity on scope, risks, controls, and evidence. These ten questions surface what matters before testing begins.
The questions
1) What is the intended use in our process?
2) What are the critical workflows and decision points?
3) What critical data is created or transformed?
4) What integrations exist and what do they transform?
5) Who are the key roles and what must they be prevented from doing?
6) What audit trail events must be captured and exported?
7) What reports drive regulated decisions?
8) What changes are expected after go-live and how will we control them?
9) What evidence will we store and where?
10) Who owns operational controls after release?
When these are answered clearly, validation becomes faster and far more defensible.
In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.